Article info
PDFConcise reports
Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
- Correspondence to:
Dr G Ruiz-Irastorza
Servicio de Medicina Interna, Hospital de Cruces, 48903-Bizkaia, Spain; r.irastorza{at}euskalnet.net
Citation
Antimalarials may influence the risk of malignancy in systemic lupus erythematosus
Publication history
- Accepted December 14, 2006
- First published January 4, 2007.
Online issue publication
April 08, 2023
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Annals of the Rheumatic Diseases